Project1170: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
Project1170 measure Sex BALB/cJ BTBR T<+> Itpr3<tf>/J C3H/HeJ C57BL/6J DBA/2J SWR/J
bw_1_cont   body weight at 4-6 wks of age , control   121657 Female
Male 10 10 10 10 10 10
bw_1_fluox   body weight at 4-6 wks of age , fluoxetine   121658 Female
Male 10 10 10 10 10 10
bw_2_cont   body weight at 6-8 wks of age , control   121659 Female
Male 10 10 10 10 10 10
bw_2_fluox   body weight at 6-8 wks of age , fluoxetine   121660 Female
Male 10 10 10 10 10 10
bw_3_cont   body weight at 7-9 wks of age , control   121661 Female
Male 10 10 10 10 10 10
bw_3_fluox   body weight at 7-9 wks of age , fluoxetine   121662 Female
Male 10 10 10 10 10 10
bw_4_cont   body weight at 10-12 wks of age , control   121663 Female
Male 10 9 10 10 10 10
bw_4_fluox   body weight at 10-12 wks of age , fluoxetine   121664 Female
Male 10 10 10 10 10 10
bw_5_cont   body weight at 11-13 wks of age , control   121665 Female
Male 10 9 10 10 9 10
bw_5_fluox   body weight at 11-13 wks of age , fluoxetine   121666 Female
Male 10 10 10 10 10 10
bw_grip_cont   body weight at time of grip strength test , control   121667 Female
Male 10 10 10 10 10 10
bw_grip_fluox   body weight at time of grip strength test , fluoxetine   121668 Female
Male 10 10 10 10 10 10
forepaw_T1_cont   grip strength forepaws, trial 1 , control   121669 Female
Male 10 10 10 10 10 10
forepaw_T1_fluox   grip strength forepaws, trial 1 , fluoxetine   121670 Female
Male 10 10 10 10 10 10
forepaw_T2_cont   grip strength forepaws, trial 2 , control   121671 Female
Male 10 10 10 10 10 10
forepaw_T2_fluox   grip strength forepaws, trial 2 , fluoxetine   121672 Female
Male 10 10 10 10 10 10
forepaw_T3_cont   grip strength forepaws, trial 3 , control   121673 Female
Male 10 10 10 10 10 10
forepaw_T3_fluox   grip strength forepaws, trial 3 , fluoxetine   121674 Female
Male 10 10 10 10 10 10
forepaw_avg_cont   grip strength forepaws, average of all trials , control   121675 Female
Male 10 10 10 10 10 10
forepaw_avg_fluox   grip strength forepaws, average of all trials , fluoxetine   121676 Female
Male 10 10 10 10 10 10
forepaw_avg_adj_cont   grip strength forepaws, average of all trials adjusted for body weight , control   121677 Female
Male 10 10 10 10 10 10
forepaw_avg_adj_fluox   grip strength forepaws, average of all trials adjusted for body weight , fluoxetine   121678 Female
Male 10 10 10 10 10 10
all_paw_T1_cont   grip strength all paws, trial 1 , control   121679 Female
Male 10 10 10 10 10 10
all_paw_T1_fluox   grip strength all paws, trial 1 , fluoxetine   121680 Female
Male 10 10 10 10 10 10
all_paw_T2_cont   grip strength all paws, trial 2 , control   121681 Female
Male 10 10 10 10 10 10
all_paw_T2_fluox   grip strength all paws, trial 2 , fluoxetine   121682 Female
Male 10 10 10 10 10 10
all_paw_T3_cont   grip strength all paws, trial 3 , control   121683 Female
Male 10 10 10 10 10 10
all_paw_T3_fluox   grip strength all paws, trial 3 , fluoxetine   121684 Female
Male 10 10 10 10 10 10
all_paw_avg_cont   grip strength all paws, average of all trials , control   121685 Female
Male 10 10 10 10 10 10
all_paw_avg_fluox   grip strength all paws, average of all trials , fluoxetine   121686 Female
Male 10 10 10 10 10 10
all_paw_avg_adj_cont   grip strength all paws, average of all trials adjusted for body weight , control   121687 Female
Male 10 10 10 10 10 10
all_paw_avg_adj_fluox   grip strength all paws, average of all trials adjusted for body weight , fluoxetine   121688 Female
Male 10 10 10 10 10 10
high_mobile_dur_1_cont   duration mouse was highly mobile, min 1 , control   121693 Female
Male 10 8 10 6 6 10
high_mobile_dur_1_fluox   duration mouse was highly mobile, min 1 , fluoxetine   121694 Female
Male 9 10 10 9 8 10
high_mobile_dur_2_cont   duration mouse was highly mobile, min 2 , control   121695 Female
Male 10 8 10 6 6 10
high_mobile_dur_2_fluox   duration mouse was highly mobile, min 2 , fluoxetine   121696 Female
Male 9 10 10 9 8 10
high_mobile_dur_3_cont   duration mouse was highly mobile, min 3 , control   121697 Female
Male 10 8 10 6 6 10
high_mobile_dur_3_fluox   duration mouse was highly mobile, min 3 , fluoxetine   121698 Female
Male 9 10 10 9 8 10
high_mobile_dur_4_cont   duration mouse was highly mobile, min 4 , control   121699 Female
Male 10 8 10 6 6 10
high_mobile_dur_4_fluox   duration mouse was highly mobile, min 4 , fluoxetine   121700 Female
Male 9 10 10 9 8 10
high_mobile_dur_5_cont   duration mouse was highly mobile, min 5 , control   121701 Female
Male 10 8 10 6 6 10
high_mobile_dur_5_fluox   duration mouse was highly mobile, min 5 , fluoxetine   121702 Female
Male 9 10 10 9 8 10
high_mobile_dur_6_cont   duration mouse was highly mobile, min 6 , control   121703 Female
Male 10 8 10 6 6 10
high_mobile_dur_6_fluox   duration mouse was highly mobile, min 6 , fluoxetine   121704 Female
Male 9 10 10 9 8 10
high_mobile_dur_7_cont   duration mouse was highly mobile, min 7 , control   121705 Female
Male 10 8 10 6 6 10
high_mobile_dur_7_fluox   duration mouse was highly mobile, min 7 , fluoxetine   121706 Female
Male 9 10 10 9 8 10
high_mobile_dur_tot_cont   duration mouse was highly mobile, total over 7 min , control   121707 Female
Male 10 8 10 6 6 10
high_mobile_dur_tot_fluox   duration mouse was highly mobile, total over 7 min , fluoxetine   121708 Female
Male 9 10 10 9 8 10
high_mobile_pct_1_cont   percentage of time mouse was highly mobile, min 1 , control   121709 Female
Male 10 8 10 6 6 10
high_mobile_pct_1_fluox   percentage of time mouse was highly mobile, min 1 , fluoxetine   121710 Female
Male 9 10 10 9 8 10
high_mobile_pct_2_cont   percentage of time mouse was highly mobile, min 2 , control   121711 Female
Male 10 8 10 6 6 10
high_mobile_pct_2_fluox   percentage of time mouse was highly mobile, min 2 , fluoxetine   121712 Female
Male 9 10 10 9 8 10
high_mobile_pct_3_cont   percentage of time mouse was highly mobile, min 3 , control   121713 Female
Male 10 8 10 6 6 10
high_mobile_pct_3_fluox   percentage of time mouse was highly mobile, min 3 , fluoxetine   121714 Female
Male 9 10 10 9 8 10
high_mobile_pct_4_cont   percentage of time mouse was highly mobile, min 4 , control   121715 Female
Male 10 8 10 6 6 10
high_mobile_pct_4_fluox   percentage of time mouse was highly mobile, min 4 , fluoxetine   121716 Female
Male 9 10 10 9 8 10
high_mobile_pct_5_cont   percentage of time mouse was highly mobile, min 5 , control   121717 Female
Male 10 8 10 6 6 10
high_mobile_pct_5_fluox   percentage of time mouse was highly mobile, min 5 , fluoxetine   121718 Female
Male 9 10 10 9 8 10
high_mobile_pct_6_cont   percentage of time mouse was highly mobile, min 6 , control   121719 Female
Male 10 8 10 6 6 10
high_mobile_pct_6_fluox   percentage of time mouse was highly mobile, min 6 , fluoxetine   121720 Female
Male 9 10 10 9 8 10
high_mobile_pct_7_cont   percentage of time mouse was highly mobile, min 7 , control   121721 Female
Male 10 8 10 6 6 10
high_mobile_pct_7_fluox   percentage of time mouse was highly mobile, min 7 , fluoxetine   121722 Female
Male 9 10 10 9 8 10
high_mobile_pct_avg_cont   percentage of time mouse was highly mobile, average over 7 min , control   121723 Female
Male 10 8 10 6 6 10
high_mobile_pct_avg_fluox   percentage of time mouse was highly mobile, average over 7 min , fluoxetine   121724 Female
Male 9 10 10 9 8 10
mobile_dur_1_cont   duration mouse was mobile, min 1 , control   121725 Female
Male 10 8 10 6 6 10
mobile_dur_1_fluox   duration mouse was mobile, min 1 , fluoxetine   121726 Female
Male 9 10 10 9 8 10
mobile_dur2_cont   duration mouse was mobile, min 2 , control   121727 Female
Male 10 8 10 6 6 10
mobile_dur2_fluox   duration mouse was mobile, min 2 , fluoxetine   121728 Female
Male 9 10 10 9 8 10
mobile_dur_3_cont   duration mouse was mobile, min 3 , control   121729 Female
Male 10 8 10 6 6 10
mobile_dur_3_fluox   duration mouse was mobile, min 3 , fluoxetine   121730 Female
Male 9 10 10 9 8 10
mobile_dur_4_cont   duration mouse was mobile, min 4 , control   121731 Female
Male 10 8 10 6 6 10
mobile_dur_4_fluox   duration mouse was mobile, min 4 , fluoxetine   121732 Female
Male 9 10 10 9 8 10
mobile_dur_5_cont   duration mouse was mobile, min 5 , control   121733 Female
Male 10 8 10 6 6 10
mobile_dur_5_fluox   duration mouse was mobile, min 5 , fluoxetine   121734 Female
Male 9 10 10 9 8 10
mobile_dur_6_cont   duration mouse was mobile, min 6 , control   121735 Female
Male 10 8 10 6 6 10
mobile_dur_6_fluox   duration mouse was mobile, min 6 , fluoxetine   121736 Female
Male 9 10 10 9 8 10
mobile_dur_7_cont   duration mouse was mobile, min 7 , control   121737 Female
Male 10 8 10 6 6 10
mobile_dur_7_fluox   duration mouse was mobile, min 7 , fluoxetine   121738 Female
Male 9 10 10 9 8 10
mobile_dur_tot_cont   duration mouse was mobile, total over 7 min , control   121739 Female
Male 10 8 10 6 6 10
mobile_dur_tot_fluox   duration mouse was mobile, total over 7 min , fluoxetine   121740 Female
Male 9 10 10 9 8 10
mobile_pct_1_cont   percentage of time mouse was mobile, min 1 , control   121741 Female
Male 10 8 10 6 6 10
mobile_pct_1_fluox   percentage of time mouse was mobile, min 1 , fluoxetine   121742 Female
Male 9 10 10 9 8 10
mobile_pct_2_cont   percentage of time mouse was mobile, min 2 , control   121743 Female
Male 10 8 10 6 6 10
mobile_pct_2_fluox   percentage of time mouse was mobile, min 2 , fluoxetine   121744 Female
Male 9 10 10 9 8 10
mobile_pct_3_cont   percentage of time mouse was mobile, min 3 , control   121745 Female
Male 10 8 10 6 6 10
mobile_pct_3_fluox   percentage of time mouse was mobile, min 3 , fluoxetine   121746 Female
Male 9 10 10 9 8 10
mobile_pct_4_cont   percentage of time mouse was mobile, min 4 , control   121747 Female
Male 10 8 10 6 6 10
mobile_pct_4_fluox   percentage of time mouse was mobile, min 4 , fluoxetine   121748 Female
Male 9 10 10 9 8 10
mobile_pct_5_cont   percentage of time mouse was mobile, min 5 , control   121749 Female
Male 10 8 10 6 6 10
mobile_pct_5_fluox   percentage of time mouse was mobile, min 5 , fluoxetine   121750 Female
Male 9 10 10 9 8 10
mobile_pct_6_cont   percentage of time mouse was mobile, min 6 , control   121751 Female
Male 10 8 10 6 6 10
mobile_pct_6_fluox   percentage of time mouse was mobile, min 6 , fluoxetine   121752 Female
Male 9 10 10 9 8 10
mobile_pct_7_cont   percentage of time mouse was mobile, min 7 , control   121753 Female
Male 10 8 10 6 6 10
mobile_pct_7_fluox   percentage of time mouse was mobile, min 7 , fluoxetine   121754 Female
Male 9 10 10 9 8 10
mobile_pct_avg_cont   percentage of time mouse was mobile, average over 7 min , control   121755 Female
Male 10 8 10 6 6 10
mobile_pct_avg_fluox   percentage of time mouse was mobile, average over 7 min , fluoxetine   121756 Female
Male 9 10 10 9 8 10
immobile_dur_1_cont   duration mouse was immobile, min 1 , control   121757 Female
Male 10 8 10 6 6 10
immobile_dur_1_fluox   duration mouse was immobile, min 1 , fluoxetine   121758 Female
Male 9 10 10 9 8 10
immobile_dur_2_cont   duration mouse was immobile, min 2 , control   121759 Female
Male 10 8 10 6 6 10
immobile_dur_2_fluox   duration mouse was immobile, min 2 , fluoxetine   121760 Female
Male 9 10 10 9 8 10
immobile_dur_3_cont   duration mouse was immobile, min 3 , control   121761 Female
Male 10 8 10 6 6 10
immobile_dur_3_fluox   duration mouse was immobile, min 3 , fluoxetine   121762 Female
Male 9 10 10 9 8 10
immobile_dur_4_cont   duration mouse was immobile, min 4 , control   121763 Female
Male 10 8 10 6 6 10
immobile_dur_4_fluox   duration mouse was immobile, min 4 , fluoxetine   121764 Female
Male 9 10 10 9 8 10
immobile_dur_5_cont   duration mouse was immobile, min 5 , control   121765 Female
Male 10 8 10 6 6 10
immobile_dur_5_fluox   duration mouse was immobile, min 5 , fluoxetine   121766 Female
Male 9 10 10 9 8 10
immobile_dur_6_cont   duration mouse was immobile, min 6 , control   121767 Female
Male 10 8 10 6 6 10
immobile_dur_6_fluox   duration mouse was immobile, min 6 , fluoxetine   121768 Female
Male 9 10 10 9 8 10
immobile_dur_7_cont   duration mouse was immobile, min 7 , control   121769 Female
Male 10 8 10 6 6 10
immobile_dur_7_fluox   duration mouse was immobile, min 7 , fluoxetine   121770 Female
Male 9 10 10 9 8 10
immobile_dur_tot_cont   duration mouse was immobile, total over 7 min , control   121771 Female
Male 10 8 10 6 6 10
immobile_dur_tot_fluox   duration mouse was immobile, total over 7 min , fluoxetine   121772 Female
Male 9 10 10 9 8 10
immobile_pct_1_cont   percentage of time mouse was immobile, min 1 , control   121773 Female
Male 10 8 10 6 6 10
immobile_pct_1_fluox   percentage of time mouse was immobile, min 1 , fluoxetine   121774 Female
Male 9 10 10 9 8 10
immobile_pct_2_cont   percentage of time mouse was immobile, min 2 , control   121775 Female
Male 10 8 10 6 6 10
immobile_pct_2_fluox   percentage of time mouse was immobile, min 2 , fluoxetine   121776 Female
Male 9 10 10 9 8 10
immobile_pct_3_cont   percentage of time mouse was immobile, min 3 , control   121777 Female
Male 10 8 10 6 6 10
immobile_pct_3_fluox   percentage of time mouse was immobile, min 3 , fluoxetine   121778 Female
Male 9 10 10 9 8 10
immobile_pct_4_cont   percentage of time mouse was immobile, min 4 , control   121779 Female
Male 10 8 10 6 6 10
immobile_pct_4_fluox   percentage of time mouse was immobile, min 4 , fluoxetine   121780 Female
Male 9 10 10 9 8 10
immobile_pct_5_cont   percentage of time mouse was immobile, min 5 , control   121781 Female
Male 10 8 10 6 6 10
immobile_pct_5_fluox   percentage of time mouse was immobile, min 5 , fluoxetine   121782 Female
Male 9 10 10 9 8 10
immobile_pct_6_cont   percentage of time mouse was immobile, min 6 , control   121783 Female
Male 10 8 10 6 6 10
immobile_pct_6_fluox   percentage of time mouse was immobile, min 6 , fluoxetine   121784 Female
Male 9 10 10 9 8 10
immobile_pct_7_cont   percentage of time mouse was immobile, min 7 , control   121785 Female
Male 10 8 10 6 6 10
immobile_pct_7_fluox   percentage of time mouse was immobile, min 7 , fluoxetine   121786 Female
Male 9 10 10 9 8 10
immobile_pct_avg_cont   percentage of time mouse was immobile, average over 7 min , control   121787 Female
Male 10 8 10 6 6 10
immobile_pct_avg_fluox   percentage of time mouse was immobile, average over 7 min , fluoxetine   121788 Female
Male 9 10 10 9 8 10
distance_tot_1_cont   total distance traveled, first 5 min , control   121789 Female
Male 10 9 10 10 9 10
distance_tot_1_fluox   total distance traveled, first 5 min , fluoxetine   121790 Female
Male 10 10 10 10 10 10
distance_tot_2_cont   total distance traveled, second 5 min , control   121791 Female
Male 10 9 10 10 9 10
distance_tot_2_fluox   total distance traveled, second 5 min , fluoxetine   121792 Female
Male 10 10 10 10 10 10
distance_tot_3_cont   total distance traveled, third 5 min , control   121793 Female
Male 10 9 10 10 9 10
distance_tot_3_fluox   total distance traveled, third 5 min , fluoxetine   121794 Female
Male 10 10 10 10 10 10
distance_tot_4_cont   total distance traveled, fourth 5 min , control   121795 Female
Male 10 9 10 10 9 10
distance_tot_4_fluox   total distance traveled, fourth 5 min , fluoxetine   121796 Female
Male 10 10 10 10 10 10
margin_time_1_cont   time spent in periphery, first 5 min , control   121797 Female
Male 10 9 10 10 9 10
margin_time_1_fluox   time spent in periphery, first 5 min , fluoxetine   121798 Female
Male 10 10 10 10 10 10
margin_time_2_cont   time spent in periphery, second 5 min , control   121799 Female
Male 10 9 10 10 9 10
margin_time_2_fluox   time spent in periphery, second 5 min , fluoxetine   121800 Female
Male 10 10 10 10 10 10
margin_time_3_cont   time spent in periphery, third 5 min , control   121801 Female
Male 10 9 10 10 9 10
margin_time_3_fluox   time spent in periphery, third 5 min , fluoxetine   121802 Female
Male 10 10 10 10 10 10
margin_time_4_cont   time spent in periphery, fourth 5 min , control   121803 Female
Male 10 9 10 10 9 10
margin_time_4_fluox   time spent in periphery, fourth 5 min , fluoxetine   121804 Female
Male 10 10 10 10 10 10
margin_dist_1_cont   distance traveled in periphery, first 5 min , control   121805 Female
Male 10 9 10 10 9 10
margin_dist_1_fluox   distance traveled in periphery, first 5 min , fluoxetine   121806 Female
Male 10 10 10 10 10 10
margin_dist_2_cont   distance traveled in periphery, second 5 min , control   121807 Female
Male 10 9 10 10 9 10
margin_dist_2_fluox   distance traveled in periphery, second 5 min , fluoxetine   121808 Female
Male 10 10 10 10 10 10
margin_dist_3_cont   distance traveled in periphery, third 5 min , control   121809 Female
Male 10 9 10 10 9 10
margin_dist_3_fluox   distance traveled in periphery, third 5 min , fluoxetine   121810 Female
Male 10 10 10 10 10 10
margin_dist_4_cont   distance traveled in periphery, fourth 5 min , control   121811 Female
Male 10 9 10 10 9 10
margin_dist_4_fluox   distance traveled in periphery, fourth 5 min , fluoxetine   121812 Female
Male 10 10 10 10 10 10
center_time_1_cont   time spent in center, first 5 min , control   121813 Female
Male 10 9 10 10 9 10
center_time_1_fluox   time spent in center, first 5 min , fluoxetine   121814 Female
Male 10 10 10 10 10 10
center_time_2_cont   time spent in center, second 5 min , control   121815 Female
Male 10 9 10 10 9 10
center_time_2_fluox   time spent in center, second 5 min , fluoxetine   121816 Female
Male 10 10 10 10 10 10
center_time_3_cont   time spent in center, third 5 min , control   121817 Female
Male 10 9 10 10 9 10
center_time_3_fluox   time spent in center, third 5 min , fluoxetine   121818 Female
Male 10 10 10 10 10 10
center_time_4_cont   time spent in center, fourth 5 min , control   121819 Female
Male 10 9 10 10 9 10
center_time_4_fluox   time spent in center, fourth 5 min , fluoxetine   121820 Female
Male 10 10 10 10 10 10
center_dist_1_cont   distance traveled in center, first 5 min , control   121821 Female
Male 10 9 10 10 9 10
center_dist_1_fluox   distance traveled in center, first 5 min , fluoxetine   121822 Female
Male 10 10 10 10 10 10
center_dist_2_cont   distance traveled in center, second 5 min , control   121823 Female
Male 10 9 10 10 9 10
center_dist_2_fluox   distance traveled in center, second 5 min , fluoxetine   121824 Female
Male 10 10 10 10 10 10
center_dist_3_cont   distance traveled in center, third 5 min , control   121825 Female
Male 10 9 10 10 9 10
center_dist_3_fluox   distance traveled in center, third 5 min , fluoxetine   121826 Female
Male 10 10 10 10 10 10
center_dist_4_cont   distance traveled in center, fourth 5 min , control   121827 Female
Male 10 9 10 10 9 10
center_dist_4_fluox   distance traveled in center, fourth 5 min , fluoxetine   121828 Female
Male 10 10 10 10 10 10
vert_time_1_cont   time spent vertical, first 5 min , control   121829 Female
Male 10 9 10 10 9 10
vert_time_1_fluox   time spent vertical, first 5 min , fluoxetine   121830 Female
Male 10 10 10 10 10 10
vert_time_2_cont   time spent vertical, second 5 min , control   121831 Female
Male 10 9 10 10 9 10
vert_time_2_fluox   time spent vertical, second 5 min , fluoxetine   121832 Female
Male 10 10 10 10 10 10
vert_time_3_cont   time spent vertical, third 5 min , control   121833 Female
Male 10 9 10 10 9 10
vert_time_3_fluox   time spent vertical, third 5 min , fluoxetine   121834 Female
Male 10 10 10 10 10 10
vert_time_4_cont   time spent vertical, fourth 5 min , control   121835 Female
Male 10 9 10 10 9 10
vert_time_4_fluox   time spent vertical, fourth 5 min , fluoxetine   121836 Female
Male 10 10 10 10 10 10
vert_count_1_cont   number of vertical episodes, first 5 min , control   121837 Female
Male 10 9 10 10 9 10
vert_count_1_fluox   number of vertical episodes, first 5 min , fluoxetine   121838 Female
Male 10 10 10 10 10 10
vert_count_2_cont   number of vertical episodes, second 5 min , control   121839 Female
Male 10 9 10 10 9 10
vert_count_2_fluox   number of vertical episodes, second 5 min , fluoxetine   121840 Female
Male 10 10 10 10 10 10
vert_count_3_cont   number of vertical episodes, third 5 min , control   121841 Female
Male 10 9 10 10 9 10
vert_count_3_fluox   number of vertical episodes, third 5 min , fluoxetine   121842 Female
Male 10 10 10 10 10 10
vert_count_4_cont   number of vertical episodes, fourth 5 min , control   121843 Female
Male 10 9 10 10 9 10
vert_count_4_fluox   number of vertical episodes, fourth 5 min , fluoxetine   121844 Female
Male 10 10 10 10 10 10
rest_time_1_cont   time spent resting, first 5 min , control   121845 Female
Male 10 9 10 10 9 10
rest_time_1_fluox   time spent resting, first 5 min , fluoxetine   121846 Female
Male 10 10 10 10 10 10
rest_time_2_cont   time spent resting, second 5 min , control   121847 Female
Male 10 9 10 10 9 10
rest_time_2_fluox   time spent resting, second 5 min , fluoxetine   121848 Female
Male 10 10 10 10 10 10
rest_time_3_cont   time spent resting, third 5 min , control   121849 Female
Male 10 9 10 10 9 10
rest_time_3_fluox   time spent resting, third 5 min , fluoxetine   121850 Female
Male 10 10 10 10 10 10
rest_time_4_cont   time spent resting, fourth 5 min , control   121851 Female
Male 10 9 10 10 9 10
rest_time_4_fluox   time spent resting, fourth 5 min , fluoxetine   121852 Female
Male 10 10 10 10 10 10
rest_count_1_cont   number of rest episodes, first 5 min , control   121853 Female
Male 10 9 10 10 9 10
rest_count_1_fluox   number of rest episodes, first 5 min , fluoxetine   121854 Female
Male 10 10 10 10 10 10
rest_count_2_cont   number of rest episodes, second 5 min , control   121855 Female
Male 10 9 10 10 9 10
rest_count_2_fluox   number of rest episodes, second 5 min , fluoxetine   121856 Female
Male 10 10 10 10 10 10
rest_count_3_cont   number of rest episodes, third 5 min , control   121857 Female
Male 10 9 10 10 9 10
rest_count_3_fluox   number of rest episodes, third 5 min , fluoxetine   121858 Female
Male 10 10 10 10 10 10
rest_count_4_cont   number of rest episodes, fourth 5 min , control   121859 Female
Male 10 9 10 10 9 10
rest_count_4_fluox   number of rest episodes, fourth 5 min , fluoxetine   121860 Female
Male 10 10 10 10 10 10
move_time_1_cont   time spent moving, first 5 min , control   121861 Female
Male 10 9 10 10 9 10
move_time_1_fluox   time spent moving, first 5 min , fluoxetine   121862 Female
Male 10 10 10 10 10 10
move_time_2_cont   time spent moving, second 5 min , control   121863 Female
Male 10 9 10 10 9 10
move_time_2_fluox   time spent moving, second 5 min , fluoxetine   121864 Female
Male 10 10 10 10 10 10
move_time_3_cont   time spent moving, third 5 min , control   121865 Female
Male 10 9 10 10 9 10
move_time_3_fluox   time spent moving, third 5 min , fluoxetine   121866 Female
Male 10 10 10 10 10 10
move_time_4_cont   time spent moving, fourth 5 min , control   121867 Female
Male 10 9 10 10 9 10
move_time_4_fluox   time spent moving, fourth 5 min , fluoxetine   121868 Female
Male 10 10 10 10 10 10
move_count_1_cont   number of moving episodes, first 5 min , control   121869 Female
Male 10 9 10 10 9 10
move_count_1_fluox   number of moving episodes, first 5 min , fluoxetine   121870 Female
Male 10 10 10 10 10 10
move_count_2_cont   number of moving episodes, second 5 min , control   121871 Female
Male 10 9 10 10 9 10
move_count_2_fluox   number of moving episodes, second 5 min , fluoxetine   121872 Female
Male 10 10 10 10 10 10
move_count_3_cont   number of moving episodes, third 5 min , control   121873 Female
Male 10 9 10 10 9 10
move_count_3_fluox   number of moving episodes, third 5 min , fluoxetine   121874 Female
Male 10 10 10 10 10 10
move_count_4_cont   number of moving episodes, fourth 5 min , control   121875 Female
Male 10 9 10 10 9 10
move_count_4_fluox   number of moving episodes, fourth 5 min , fluoxetine   121876 Female
Male 10 10 10 10 10 10
stereo_time_1_cont   time spent in stereotypic movement, first 5 min , control   121877 Female
Male 10 9 10 10 9 10
stereo_time_1_fluox   time spent in stereotypic movement, first 5 min , fluoxetine   121878 Female
Male 10 10 10 10 10 10
stereo_time_2_cont   time spent in stereotypic movement, second 5 min , control   121879 Female
Male 10 9 10 10 9 10
stereo_time_2_fluox   time spent in stereotypic movement, second 5 min , fluoxetine   121880 Female
Male 10 10 10 10 10 10
stereo_time_3_cont   time spent in stereotypic movement, third 5 min , control   121881 Female
Male 10 9 10 10 9 10
stereo_time_3_fluox   time spent in stereotypic movement, third 5 min , fluoxetine   121882 Female
Male 10 10 10 10 10 10
stereo_time_4_cont   time spent in stereotypic movement, fourth 5 min , control   121883 Female
Male 10 9 10 10 9 10
stereo_time_4_fluox   time spent in stereotypic movement, fourth 5 min , fluoxetine   121884 Female
Male 10 10 10 10 10 10
stereo_count_1_cont   number of stereotypic movements, first 5 min , control   121885 Female
Male 10 9 10 10 9 10
stereo_count_1_fluox   number of stereotypic movements, first 5 min , fluoxetine   121886 Female
Male 10 10 10 10 10 10
stereo_count_2_cont   number of stereotypic movements, second 5 min , control   121887 Female
Male 10 9 10 10 9 10
stereo_count_2_fluox   number of stereotypic movements, second 5 min , fluoxetine   121888 Female
Male 10 10 10 10 10 10
stereo_count_3_cont   number of stereotypic movements, third 5 min , control   121889 Female
Male 10 9 10 10 9 10
stereo_count_3_fluox   number of stereotypic movements, third 5 min , fluoxetine   121890 Female
Male 10 10 10 10 10 10
stereo_count_4_cont   number of stereotypic movements, fourth 5 min , control   121891 Female
Male 10 9 10 10 9 10
stereo_count_4_fluox   number of stereotypic movements, fourth 5 min , fluoxetine   121892 Female
Male 10 10 10 10 10 10
clockwise_1_cont   number of clockwise movements, first 5 min , control   121893 Female
Male 10 9 10 10 9 10
clockwise_1_fluox   number of clockwise movements, first 5 min , fluoxetine   121894 Female
Male 10 10 10 10 10 10
clockwise_2_cont   number of clockwise movements, second 5 min , control   121895 Female
Male 10 9 10 10 9 10
clockwise_2_fluox   number of clockwise movements, second 5 min , fluoxetine   121896 Female
Male 10 10 10 10 10 10
clockwise_3_cont   number of clockwise movements, third 5 min , control   121897 Female
Male 10 9 10 10 9 10
clockwise_3_fluox   number of clockwise movements, third 5 min , fluoxetine   121898 Female
Male 10 10 10 10 10 10
clockwise_4_cont   number of clockwise movements, fourth 5 min , control   121899 Female
Male 10 9 10 10 9 10
clockwise_4_fluox   number of clockwise movements, fourth 5 min , fluoxetine   121900 Female
Male 10 10 10 10 10 10
c_clockwise_1_cont   number of counter-clockwise movements, first 5 min , control   121901 Female
Male 10 9 10 10 9 10
c_clockwise_1_fluox   number of counter-clockwise movements, first 5 min , fluoxetine   121902 Female
Male 10 10 10 10 10 10
c_clockwise_2_cont   number of counter-clockwise movements, second 5 min , control   121903 Female
Male 10 9 10 10 9 10
c_clockwise_2_fluox   number of counter-clockwise movements, second 5 min , fluoxetine   121904 Female
Male 10 10 10 10 10 10
c_clockwise_3_cont   number of counter-clockwise movements, third 5 min , control   121905 Female
Male 10 9 10 10 9 10
c_clockwise_3_fluox   number of counter-clockwise movements, third 5 min , fluoxetine   121906 Female
Male 10 10 10 10 10 10
c_clockwise_4_cont   number of counter-clockwise movements, fourth 5 min , control   121907 Female
Male 10 9 10 10 9 10
c_clockwise_4_fluox   number of counter-clockwise movements, fourth 5 min , fluoxetine   121908 Female
Male 10 10 10 10 10 10